Stay updated on Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision v3.5.4 was added to the study's record, replacing the previous v3.5.3. This signals a new version of the page, likely reflecting minor updates to the study record or its metadata rather than a substantive change to study content.
    Difference
    0.0%
    Check dated 2026-05-15T04:46:49.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page's revision tag updated to v3.5.3, replacing the previous v3.5.2. This indicates an update to the page version rather than changes to the study data or visible content.
    Difference
    0.0%
    Check dated 2026-04-30T17:42:26.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision updated to v3.5.2, replacing the previous v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T10:44:32.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0. The previous revision v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-18T18:02:31.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T15:25:35.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Study status updated to Completed with 137 participants enrolled and a completion date of 2026-01-28, with the record revision to v3.4.2. The previous funding notice and the 'Active, not recruiting' indicator were removed.
    Difference
    0.7%
    Check dated 2026-02-11T09:27:03.000Z thumbnail image

Stay in the know with updates to Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial page.